These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1684869)

  • 21. [Potential for dependence of analgesics and psychopharmaceuticals].
    Hoffmeister F
    Arzneimittelforschung; 1984; 34(9A):1096-107. PubMed ID: 6541933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.
    Mello NK; Kamien JB; Lukas SE; Drieze J; Mendelson JH
    Neuropsychopharmacology; 1993 Jan; 8(1):45-55. PubMed ID: 8381011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosage choices of rats for morphine, for heroin, and between morphine and heroin.
    Hutto CW; Crowder WF
    Pharmacol Biochem Behav; 1997 Sep; 58(1):133-40. PubMed ID: 9264081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strain differences in the analgesic and reinforcing action of morphine in mice.
    Semenova S; Kuzmin A; Zvartau E
    Pharmacol Biochem Behav; 1995 Jan; 50(1):17-21. PubMed ID: 7700949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
    Morgan D; Cook CD; Smith MA; Picker MJ
    Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA; French AM
    Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
    Baker AK; Hoffmann VL; Meert TF
    Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon.
    Lukas SE; Brady JV; Griffiths RR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):924-31. PubMed ID: 3746670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rewarding or aversive effects of buprenorphine/naloxone combination (Suboxone) depend on conditioning trial duration.
    Canestrelli C; Marie N; Noble F
    Int J Neuropsychopharmacol; 2014 Sep; 17(9):1367-73. PubMed ID: 24606726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid drugs and their receptors. A summary of the present state of knowledge.
    Offermeier J; van Rooyen JM
    S Afr Med J; 1984 Aug; 66(8):299-305. PubMed ID: 6147901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social influences on morphine conditioned place preference in adolescent mice.
    Cole SL; Hofford RS; Evert DJ; Wellman PJ; Eitan S
    Addict Biol; 2013 Mar; 18(2):274-85. PubMed ID: 22339796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.
    Altarifi AA; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2015 Feb; 352(2):208-17. PubMed ID: 25406170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New morphine-type analgesics in anesthesia].
    Lehot JJ; Bastien O; Girard C; Ruynat L; Tartulier M
    Cah Anesthesiol; 1985; 33(3):239-47. PubMed ID: 2861882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.